PMC · DOI:10.3389/froh.2025.1635675·June 16, 2025
Editorial: Immuno-oncologic biomarker signatures for personalized immunotherapy and immunoprevention in oral squamous cell carcinoma
Rania H. Younis, Ranee Mehra, Nikolaos G. Nikitakis
Abstract
Linked entities
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Diseases1
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses · Head and Neck Cancer Studies